Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy
This review discusses the potential of circulating epigenetic biomarkers, such as methylated DNA and microRNAs, in the early detection and management of lung cancer and malignant mesothelioma. It highlights the limitations of current diagnostic methods and emphasizes the promise of liquid biopsy techniques in improving early diagnosis and treatment monitoring.
June 26, 2025
No Comments